T-Cell Leukemia Translocation Altered (TCTA) (Middle Region) Peptid
TCTA
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN984927
150,78 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 15 bis 22 Werktagen
Kurzübersicht für T-Cell Leukemia Translocation Altered (TCTA) (Middle Region) Peptid (ABIN984927)
Target
TCTA
(T-Cell Leukemia Translocation Altered (TCTA))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-TCTA antibody (Catalog #: ARP49704_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- TCTA (T-Cell Leukemia Translocation Altered (TCTA))
-
Hintergrund
-
A chromosomal aberration, translocation t(1,3)(p34,p21), involving TCTA is associated with T-cell acute lymphoblastic leukemia (T-ALL).
Alias Symbols: -
Protein Interaction Partner: SMAD4
Protein Size: 103 -
Molekulargewicht
- 11 kDa
-
Gen-ID
- 6988
-
NCBI Accession
- NM_022171, NP_071503
-
UniProt
- P57738
Target
-
Sie sind hier:
